Dr. Georgina Long

Melanoma is a key cancer type for developing and testing immunotherapies prior to broader clinical application across other malignancies.

The overall survival rate in patients with melanoma has increased exponentially in the past decade. But thanks to the use of combinations in the treatment of melanoma, the future looks even brighter, according to one expert from the Melanoma Institute Australia.